Bioactivity | DZ-837 is a PROTAC targeting BCL6. DZ-837 consists of PROTAC target protein ligand BCL6 ligand-2 (HY-161990), E3 ubiquitin ligase ligand Thalidomide-4-OH (HY-103596), and PROTAC Linker (HY-W245803), among which the conjugate of E3 ubiquitin ligase ligand + Linker is 2-(2,6-Dioxopiperidin-3-yl)-4-((2-(2-hydroxyethoxy)ethyl)amino)isoindoline-1,3-dione (HY-W924949)[1]. |
Target | BCL6 |
Formula | C42H44FN9O7S |
Molar Mass | 837.92 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |